MedPath
FDA Approval

Cystadane

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Orphan Europe SARL
DUNS: 767598352
Effective Date
March 5, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Betaine(1 g in 1 g)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Orphan Europe SARL

767598352

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Ropack Pharmaceutical

Orphan Europe SARL

Orphan Europe SARL

209989631

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cystadane

Product Details

NDC Product Code
52276-401
Route of Administration
ORAL
Effective Date
March 5, 2018
BetaineActive
Code: 3SCV180C9WClass: ACTIBQuantity: 1 g in 1 g
© Copyright 2025. All Rights Reserved by MedPath